On November 22, 2022 Ascendis Pharma A/S (Nasdaq: ASND) reported that the company is scheduled to participate in the 5th Annual Evercore ISI HealthCONx Conference (Press release, Ascendis Pharma, NOV 22, 2022, https://ascendispharma.gcs-web.com/news-releases/news-release-details/ascendis-pharma-participate-5th-annual-evercore-isi-healthconx [SID1234624327]). Company executives will participate in a virtual fireside chat hosted by Evercore.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details:

Event 5th Annual Evercore ISI HealthCONx Conference
Location Virtual
Date Thursday, December 1, 2022
Time 1:00-1:20 p.m. Eastern Time / 10:00-10:20 a.m. Pacific Time
A live webcast of the event will be available on the Investors & News section of the Ascendis Pharma website at View Source A webcast replay will also be available on this website shortly after conclusion of the event for 30 days.